Loading...

SGMT SAGIMET BIOSCIENCES INC Investments/Divestments 8-K Filing

SGMT

SGMT

SAGIMET BIOSCIENCES INC

(SGMT)

2023 8-K

Show Summary

Show Summary

Product Expansion

Financial Statements

Financial Results

Investor Update

Investor Update

Financial Results

Financial Results

Appointment of Directors

Update of Investor Presenta...

Amendment to Press Release

Annual Meeting and Clinical...

Update Presentation

Financial Results Announcement

Appointment of CFO

Financial Results and Board...

Appointment of Interim Prin...

Financial Condition Update

Update and Positive Trial R...

Departure of CFO

Equity Grants to Executive ...

Earnings Report

Presentation Update

Update and Press Release

Earnings Reports

Update Presentation

Appointment of CFO

External Links:

Sagimet Biosciences Inc. updated its slide presentation and issued a press release regarding its Phase 3 clinical trial for treatment of recurrent glioblastoma.

AI Assistant

SAGIMET BIOSCIENCES INC

2023

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.